Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Treatment-related serious adverse events in phase II/III clinical development program
| Treatment-related serious adverse event | Dalbavancin (N = 1778) | Comparator (N = 1224) |
|---|---|---|
| Total | 3 (0.2) | 9 (0.7) |
| Leukopenia | 1 (0.1) | 0 |
| Anaphylactoid reaction | 1 (0.1) | 0 |
| Cellulitis | 1 (0.1) | 1 (0.1) |
| Renal failure acute | 0 | 2 (0.2) |
| Gastrointestinal disorder | 0 | 1 (0.1) |
| Face edema | 0 | 1 (0.1) |
| Pancytopenia | 0 | 1 (0.1) |
| Thrombocytopenia | 0 | 1 (0.1) |
| Nephropathy toxic | 0 | 1 (0.1) |
| Pancreatitis acute | 0 | 1 (0.1) |
